Cheryl Satin

Recent representative matters include acting for:

Financial Services/Insurance

• Royal Bank of Canada on its C$13.5-billion acquisition of HSBC Bank of Canada

• Ontario Teachers Pension Plan Board on its acquisition of HomeQ Corporation, the parent company of Home Equity Bank

• Pacific Equity Partners on its C$165-million divestiture of AST Investor Services Inc. (Canada) and AST Trust Company (Canada) to the TMX Group Limited

• Intact Financial Corporation on its C$1-billion acquisition of The Guarantee Company of North America and MGA Frank Cowan Company Limited

• Republic Financial Holdings Limited on its acquisition of Scotiabank's Caribbean banking operations

• Transamerica/Aegon on the C$600-million sale of its business in Canada to Wilton Re/CPPIB

• VRG Capital in connection with its backing of a management buy-out of Jones Brown Inc. and the subsequent sale of Jones Brown to Arthur J. Gallagher & Co.

• Three leading Canadian trust companies in connection with the divestitures of their corporate trust and stock transfer businesses

• Intact Financial Corporation with its C$2.6-billion acquisition of the Canadian insurance businesses of AXA S.A

Life Sciences

• GlaxoSmithKline Biologicals S.A. on its advanced purchase agreement with the Government of Canada for the supply of adjuvanted COVID-19 vaccines in collaboration with Sanofi

• GlaxoSmithKline Biologicals S.A. on its collaboration agreement with Medicago Inc. to develop, manufacture and distribute a COVID-19 candidate vaccine

• GlaxoSmithKline Inc. on its supply agreement to provide the Government of Canada with its COVID-19 monoclonal antibody therapy

• Catalent Pharma Solutions Ltd., as Canadian counsel, on its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc.

• A large multinational provider of electronic and electronical products, systems and solutions on the Canadian aspects of a multi-billion dollar sale of their global medical device business

• A private equity firm in connection with its acquisition and continuing consolidation of specialist dental and orthodontist practices across Canada

• GlaxoSmithKline plc, as Canadian counsel, in connection with the Canadian aspects of its major three-part inter-conditional transaction with Novartis AG involving its vaccines, oncology and consumer healthcare businesses (this deal was named Matter of the Year in the 2015 GCR Awards)

Other Recent M&A

• Equinix, Inc. on its C$1.04-billion acquisition of 25 data-centre facilities across Canada from BCE Inc.

• Maple Leaf Foods on its acquisition of LightLife Foods

• Maple Leaf Foods Inc. on the sale of its animal nutrition and Rothsay businesses

Cheryl is recognized in:

• IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms 2023 (M&A)
  

• The Canadian Legal Lexpert Directory 2023 (Corporate Mid-Market, Private Equity and Life Sciences)
  

• Chambers Canada: Canada’s Leading Lawyers for Business – 2022–2023 (Life Sciences: Corporate/Commercial)

• The Best Lawyers in Canada 2023 (Health Care Law)

• IFLR1000: The Guide to the World's Leading Financial and Corporate Law Firms – 2022 (M&A)

• The Canadian Legal Lexpert Directory 2022 (Corporate Mid-Market, Corporate Commercial Law, Private Equity, Life Sciences & Health, Mergers & Acquisitions)

• The Best Lawyers in Canada – 2021–2022 (Health Care Law)

• The Canadian Legal Lexpert Directory 2021 (Corporate Mid-Market and Mergers & Acquisitions)

• Chambers Canada: Canada’s Leading Lawyers for Business – 2020–2021 (Life Sciences)

• Thomson Reuters Stand-out Lawyer 2021 – Independently Rated Lawyers (As nominated by senior in-house counsel)

• Who's Who Legal: Life Sciences 2016

• The Lexpert Guide to the Leading US/Canada Cross-Border Corporate Lawyers in Canada 2015 (Corporate Lawyers to Watch)

Admitted to the Ontario Bar – 2000
LLB, University of Western Ontario – 1998